David Bernstein

2.5k total citations
19 papers, 1.0k citations indexed

About

David Bernstein is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Bernstein has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 7 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in David Bernstein's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Disease and Transplantation (5 papers). David Bernstein is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (7 papers) and Liver Disease and Transplantation (5 papers). David Bernstein collaborates with scholars based in United States, Australia and Switzerland. David Bernstein's co-authors include Ira M. Jacobson, Dennis A. Revicki, Jesse Green, Leah Kleinman, Paul Y. Kwo, Kris V. Kowdley, Nezam H. Afdhal, Stuart C. Gordon, Mitchell L. Shiffman and W. Ray Kim and has published in prestigious journals such as The Lancet, The Journal of Immunology and Gastroenterology.

In The Last Decade

David Bernstein

18 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Bernstein United States 10 893 774 136 86 84 19 1.0k
Nai‐Jen Hou Taiwan 16 943 1.1× 917 1.2× 65 0.5× 115 1.3× 79 0.9× 38 1.1k
Federica Invernizzi Italy 15 568 0.6× 536 0.7× 143 1.1× 45 0.5× 106 1.3× 51 831
Carmela Cacciapuoti Italy 11 663 0.7× 628 0.8× 84 0.6× 55 0.6× 41 0.5× 20 925
Jacinta A. Holmes Australia 20 629 0.7× 612 0.8× 105 0.8× 36 0.4× 97 1.2× 51 947
Nathalie Giuily France 13 1.3k 1.5× 1.3k 1.6× 86 0.6× 73 0.8× 239 2.8× 23 1.4k
Ewa Janczewska Poland 13 718 0.8× 713 0.9× 146 1.1× 54 0.6× 33 0.4× 68 860
J.‐P. Bronowicki France 15 589 0.7× 465 0.6× 81 0.6× 73 0.8× 88 1.0× 31 731
Philippe J. Zamor United States 11 944 1.1× 781 1.0× 311 2.3× 65 0.8× 42 0.5× 21 1.1k
Claudio Puoti Italy 17 946 1.1× 840 1.1× 33 0.2× 66 0.8× 128 1.5× 40 1.1k
Themistoklis Vassiliadis Greece 17 371 0.4× 427 0.6× 44 0.3× 83 1.0× 117 1.4× 28 657

Countries citing papers authored by David Bernstein

Since Specialization
Citations

This map shows the geographic impact of David Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bernstein more than expected).

Fields of papers citing papers by David Bernstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bernstein. The network helps show where David Bernstein may publish in the future.

Co-authorship network of co-authors of David Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of David Bernstein. A scholar is included among the top collaborators of David Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bernstein. David Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lee, Susan, et al.. (2024). Preventing Readmissions for Hepatic Encephalopathy. Clinics in Liver Disease. 28(2). 345–358.
2.
Brown, Robert S., et al.. (2023). Improving the Management of Hepatorenal Syndrome-Acute Kidney Injury Using an Updated Guidance and a New Treatment Paradigm.. PubMed. 19(9). 527–536. 2 indexed citations
3.
Bernstein, David, et al.. (2019). 957 Awareness and Utilization of the Baveno VI Criteria to Predict Gastroesophageal Varices in Compensated Cirrhotic Patients. The American Journal of Gastroenterology. 114(1). S555–S557. 1 indexed citations
4.
Younossi, Zobair M., David Bernstein, Mitchell L. Shiffman, et al.. (2018). Diagnosis and Management of Primary Biliary Cholangitis. The American Journal of Gastroenterology. 114(1). 48–63. 126 indexed citations
5.
Poordad, Fred, Stanislas Pol, Armen Asatryan, et al.. (2017). Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure. Hepatology. 67(4). 1253–1260. 105 indexed citations
6.
Poordad, Fred, Stanislas Pol, Armen Asatryan, et al.. (2017). MAGELLAN-1, Part 2: Glecaprevir and Pibrentasvir for 12 or 16 Weeks in Patients with Chronic HCV Genotype 1 or 4 and Prior Direct-Acting Antiviral Treatment Failure. Gastroenterology. 152(5). S1057–S1057. 8 indexed citations
7.
Poordad, Fred, Stanislas Pol, Armen Asatryan, et al.. (2017). MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure. Journal of Hepatology. 66(1). S83–S84. 13 indexed citations
8.
Bernstein, David, et al.. (2016). Sa1543 Inpatient Hepatitis C Screening at Teaching Medical Centers: An Opportunity for Improvement. Gastroenterology. 150(4). S1062–S1062. 1 indexed citations
9.
Poordad, Fred, Stuart C. Gordon, Armen Asatryan, et al.. (2016). High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study. Journal of Hepatology. 64(2). S160–S161. 16 indexed citations
10.
11.
12.
13.
Jacobson, Ira M., Robert S. Brown, Bradley Freilich, et al.. (2007). Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients. Hepatology. 46(4). 971–981. 221 indexed citations
14.
Ahmed, Furqaan, Ira M. Jacobson, Robert S. Brown, et al.. (2003). Clinical significance of pegylated interferon induced neutropenia: Results from the WIN-R trial. Gastroenterology. 124(4). A700–A700. 5 indexed citations
15.
16.
Bernstein, David, et al.. (2002). Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology. 35(3). 704–708. 191 indexed citations
17.
Bisceglie, Adrian M. Di, David Bernstein, V. Rustgi, et al.. (2001). Pegylated (40 KDA) interferon alfa-2a (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study. Journal of Hepatology. 34. 143–143. 9 indexed citations
18.
Bernstein, David & Richard Phillips. (1996). Portal Hypertensive Gastropathy. Gastrointestinal Endoscopy Clinics of North America. 6(4). 697–708. 12 indexed citations
19.
Bernstein, David, et al.. (1951). Effect of Hypoglycemia on Rats with Intrasplenic Adrenal Transplants.. Experimental Biology and Medicine. 78(1). 215–217. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nai‐Jen Hou Breakdown of academic impact, for papers by Federica Invernizzi Breakdown of academic impact, for papers by Carmela Cacciapuoti Breakdown of academic impact, for papers by Jacinta A. Holmes Breakdown of academic impact, for papers by Nathalie Giuily Breakdown of academic impact, for papers by Ewa Janczewska Breakdown of academic impact, for papers by J.‐P. Bronowicki Breakdown of academic impact, for papers by Philippe J. Zamor Breakdown of academic impact, for papers by Claudio Puoti Breakdown of academic impact, for papers by Themistoklis Vassiliadis
Rankless by CCL
2026